VAXCYTE Insider Moves: Jim Buys Low, Sells High to Fuel Vaccine Expansion
VAXCYTE insiders buy low and sell high, backing the company’s vaccine push and $500M fundraise—insider moves reveal confidence and strategic growth.
3 minutes to read
VAXCYTE INC